Rafferty Asset Management
VTVT icon

Rafferty Asset Management’s vTv Therapeutics VTVT Stock Holding History

Rafferty Asset Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,727
Closed -$69K – 1330
2021
Q4 		$69K Buy
1,727
+364
+27% +$19.5K ﹤0.01% 1275
2021
Q3 		$83K Buy
+1,363
New +$103K ﹤0.01% 1244

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Rafferty Asset Management's VTVT Position: Q1 2022 in Review

Rafferty Asset Management sold out of vTv Therapeutics (VTVT) in Q1 2022, closing a stake of 1,727 shares — an estimated $69K sold.

Rafferty Asset Management first reported a position in VTVT in Q3 2021 and held it in 2 quarters. The position peaked at $83K in Q3 2021. 24 funds tracked by Wall St. Rank hold VTVT as of Q1 2022.

  • Rafferty Asset Management reported no remaining vTv Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 1,727 vTv Therapeutics shares in Q1 2022, an estimated $69K.
  • Rafferty Asset Management first reported a position in vTv Therapeutics in Q3 2021 and held it in 2 quarters.
  • Rafferty Asset Management's vTv Therapeutics position peaked at $83K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2022.

Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.